Close

AstraZeneca (AZN), Ironwood (IRWD) Announce All Primary, Secondary Endpoints Met in Linaclotide Phase 3

July 8, 2015 8:03 AM EDT Send to a Friend
AstraZeneca (NYSE: AZN) and Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) announced today that top-line data demonstrate linaclotide met all primary and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login